Prior to the outbreak of COVID-19, the healthcare industry in the United States was in the midst of an intense refocusing on patient-centered care. This evolution was defined by a number of innovations, policies, and even federal reimbursement programs that prioritized emphasis on and impact on the patient experience. It led to changes in everything from the quality of hospital food, valet parking, and room amenities to fundamentally reimagined standards of care for even mundane procedures like
Read More
Abbott
2020 Fortune/IBM Watson Health 100 Top Hospitals List
What You Should
Know:
- Fortune and
IBM Watson Health named the 100 Top Hospitals that are setting new standards
for using technology to improve operational efficiency, quality care and
safety.
- The rapid shift to virtual care amid COVID-19 put a bigger spotlight on the barriers impeding digital transformation, but this year’s top hospitals are leading the way for practical approaches to using telehealth and predictive modeling as well as data as a foundational measure to align
Read More
In-Depth: 32 FDA-Approved COVID-19 Testing Kits
What You Should Know:
- In-depth look list of FDA-approved COVID-19 test kits
The U.S. Food and Drug Administration (FDA) offers emergency use authorizations (EUAs) for unapproved products or new uses for approved items in urgent situations where no suitable alternatives exist. Dozens of companies have sought and received EUAs for their testing kits that screen for SARS-CoV-2 — more commonly referred to as COVID-19 or the novel coronavirus.
The FDA makes a
Read More
Omada Health Integrates With Abbot’s Freestyle Libre for People with Type 2 Diabetes
- Collaboration combines Abbott′s world-leading glucose sensing technology with Omada Health's best-in-class, proprietary digital coaching platform to provide personalized, on-the-go care.- As part of Omada’s expanded Type 2 diabetes offering, FreeStyle Libre will be the exclusive CGM delivered directly to participants’ doorsteps – expanding access to the technology for more people with diabetes.Abbott and Omada Health announced they are partnering to integrate Abbott's revolutionary FreeStyle
Read More
Abbott and Sanofi Partner to Integrate Glucose Sensing and Insulin Data
- Abbott (ABT) and Sanofi partner to integrate to developing tools that combine the FreeStyle Libre technology with Sanofi′s insulin dosing information for future smartpens, insulin titration apps and cloud software. - The integration will enable both people with diabetes and their doctors to make better-informed treatment decisions around medication, nutrition, and lifestyle.Abbott (ABT) and Sanofi, today announced they are partnering to integrate glucose sensing and insulin delivery
Read More
What’s the Difference: A Look at Consumer and Medical-Grade Wearables in Healthcare
Can both consumer and medical-grade wearables work together to fill healthcare’s care gaps? Dr. Sunil Kapur shares his insights.
What does Abbott’s Confirm Rx insertable cardiac monitor (ICM) and the latest Apple Watch have in common? The answer: more than you think, and perhaps not nearly enough. Today, consumer and medical-grade wearables may live in different markets, but they are aligning on a similar long-term objective—capturing critical data to improve outcomes.
“People want to
Read More
Abbott Integrates Insulin Dose Data with Novo Nordisk Insulin Pens
Abbott and Novo Nordisk today announced a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly into the digital health tools compatible with the FreeStyle Libre system (FreeStyle LibreLinkii mobile app and LibreViewiii cloud-based system). The integration between Abbott and Novo Nordisk’s products will enable healthcare professionals, caregivers and people with diabetes to view glucose and insulin data together to help
Read More
